Stocks / NASDAQ / La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company

Our Opinion

La Jolla Pharmaceutical Company is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“LJPC-401 has been shown to be effective in reducing serum iron in preclinical testing. Specifically, La Jolla has completed animal toxicology studies that demonstrated a dose-dependent reduction in serum iron levels in all species tested.” Read the following article

Company Description

La Jolla Pharmaceutical Co. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. LJPC-501 is the proprietary formulation for angiotensin II. The LJPC-401 is the formulation of hepcidin, which is an endogenous peptide hormone. The LJPC-30Sa and LJPC-30Sb are the next generation gentamicin derivatives, which is an antibiotic for kidney toxicity. The company was founded in 1989 and is headquartered in San Diego, CA. [Source: MarketWatch]

Company Website: